Join
Live feed
·
INSIDERFilingvia Quantisnow
Centessa Pharmaceuticals plc logo

Chief Accounting Officer Deferiere Raphael was granted 11,000 units of Ordinary Shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CNTA· Centessa Pharmaceuticals plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTA (Centessa Pharmaceuticals plc) and more on Quantisnow.